Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13149)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 14, 2016 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol 2016; 22(30): 6829-6840 [PMID: 27570420 DOI: 10.3748/wjg.v22.i30.6829] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i30/6829.htm |
| Number | Citing Articles |
| 1 |
Xin Zhang, Hejing Huang, Dejun Yang, Peng Wang, Xin Huang, Zunqi Hu, Yu Zhang, Ronglin Yan, Zhenxin Zhu, Qingping Cai. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211036310
|
| 2 |
Mitsuro Kanda, Yuuya Kasahara, Dai Shimizu, Takashi Miwa, Shinichi Umeda, Koichi Sawaki, Shunsuke Nakamura, Yasuhiro Kodera, Satoshi Obika. Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer. Molecular Therapy - Nucleic Acids 2020; 22: 791 doi: 10.1016/j.omtn.2020.10.001
|
| 3 |
Koichi Sawaki, Mitsuro Kanda, Yasuhiro Kodera. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer. Expert Review of Gastroenterology & Hepatology 2018; 12(7): 657 doi: 10.1080/17474124.2018.1489233
|
| 4 |
Tommaso Zurleni, Elson Gjoni, Michele Altomare, Stefano Rausei. Conversion surgery for gastric cancer patients: A review. World Journal of Gastrointestinal Oncology 2018; 10(11): 398-409 doi: 10.4251/wjgo.v10.i11.398
|
| 5 |
Koji Nakamura, Kenjiro Sawada, Masaki Kobayashi, Mayuko Miyamoto, Aasa Shimizu, Misa Yamamoto, Yasuto Kinose, Tadashi Kimura. Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target. Cancers 2019; 11(8): 1147 doi: 10.3390/cancers11081147
|
| 6 |
Miguel Alberto, Andreas Brandl, Pankaj Kumar Garg, Safak Gül-Klein, Mathias Dahlmann, Ulrike Stein, Beate Rau. Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview. Clinical & Experimental Metastasis 2019; 36(1): 1 doi: 10.1007/s10585-019-09955-4
|
| 7 |
Shunsuke Nakamura, Mitsuro Kanda, Yasuhiro Kodera. Incorporating molecular biomarkers into clinical practice for gastric cancer. Expert Review of Anticancer Therapy 2019; 19(9): 757 doi: 10.1080/14737140.2019.1659136
|
| 8 |
Rodolfo T.C. Takaoka, Nathália D. Sertório, Lara P.J. Magalini, Leandro M. Dos Santos, Helena R. Souza, Melina M. Iyomasa-Pilon, Lucas Possebon, Sara S. Costa, Ana P. Girol. Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias. Pathology - Research and Practice 2018; 214(2): 181 doi: 10.1016/j.prp.2017.12.003
|
| 9 |
Muhammad Furqan Akhtar, Ammara Saleem, Azhar Rasul, Mirza Muhammad Faran Ashraf Baig, May Bin-Jumah, Mohamed M. Abdel Daim. Anticancer natural medicines: An overview of cell signaling and other targets of anticancer phytochemicals. European Journal of Pharmacology 2020; 888: 173488 doi: 10.1016/j.ejphar.2020.173488
|
| 10 |
Omar Elakad, Yuchan Li, Natascha Gieser, Sha Yao, Stefan Küffer, Marc Hinterthaner, Bernhard C. Danner, Alexander von Hammerstein-Equord, Philipp Ströbel, Hanibal Bohnenberger, Jie Mei. Role of Annexin A1 in Squamous Cell Lung Cancer Progression. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/5520832
|
| 11 |
Shuchang Wang, Lulu Wo, Zizhen Zhang, Chunchao Zhu, Chaojie Wang, Yangyang Wang, Lechun Hou, Hui Cao, Qian Zhao, Enhao Zhao. Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer. Cancer Letters 2022; 549: 215916 doi: 10.1016/j.canlet.2022.215916
|
| 12 |
Catherine R. Lewis, Neda Dadgar, Samuel A. Yellin, Vera S. Donnenberg, Albert D. Donnenberg, David L. Bartlett, Casey J. Allen, Patrick L. Wagner. Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor Environment. Cancers 2023; 15(20): 5107 doi: 10.3390/cancers15205107
|
| 13 |
Yoon-Koo Kang, Satoshi Morita, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Hiroki Sameshima, Li-Tzong Chen, Narikazu Boku. Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study. Gastric Cancer 2022; 25(1): 207 doi: 10.1007/s10120-021-01230-4
|
| 14 |
Satoshi Tomizawa, Shigetsugu Takano, Ryotaro Eto, Tsukasa Takayashiki, Satoshi Kuboki, Masayuki Ohtsuka. Semaphorin 3 C enhances putative cancer stemness and accelerates peritoneal dissemination in pancreatic cancer. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03008-3
|
| 15 |
Long Bai, Yujing Guan, Yeqian Zhang, Jiayi Gu, Bo Ni, Hao-yu Zhang, Muerzhate Aimaiti, Shuchang Wang, Ben Yue, Xiang Xia, Zizhen Zhang. Effectiveness of peritoneal lavage fluid circulating tumour cells and circulating tumour DNA in the prediction of metachronous peritoneal metastasis of gastric cancer (pT4NxM0/pT1-3N+M0) after radical resection: protocol of a prospective single-centre clinical study. BMJ Open 2024; 14(10): e083659 doi: 10.1136/bmjopen-2023-083659
|
| 16 |
Shuichi Sakamoto, Shunsuke Kagawa, Kazuya Kuwada, Atene Ito, Hiroki Kajioka, Yoshihiko Kakiuchi, Megumi Watanabe, Tetsuya Kagawa, Ryuichi Yoshida, Satoru Kikuchi, Shinji Kuroda, Hiroshi Tazawa, Toshiyoshi Fujiwara. Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer. OncoImmunology 2019; 8(12): e1671760 doi: 10.1080/2162402X.2019.1671760
|
| 17 |
Q.B. Tran, R. Mizumoto, S. Ratnayake, B. Strekozov. Metastatic gastric adenocarcinoma and synchronous carcinoid tumour mimicking appendicitis: A case report. International Journal of Surgery Case Reports 2018; 44: 93 doi: 10.1016/j.ijscr.2018.02.023
|
| 18 |
Yuko Nagamura, Makoto Miyazaki, Yoshiko Nagano, Arata Tomiyama, Rieko Ohki, Kazuyoshi Yanagihara, Ryuichi Sakai, Hideki Yamaguchi. SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling. Cancers 2021; 13(17): 4309 doi: 10.3390/cancers13174309
|
| 19 |
Alessio Biagioni, Ileana Skalamera, Sara Peri, Nicola Schiavone, Fabio Cianchi, Elisa Giommoni, Lucia Magnelli, Laura Papucci. Update on gastric cancer treatments and gene therapies. Cancer and Metastasis Reviews 2019; 38(3): 537 doi: 10.1007/s10555-019-09803-7
|
| 20 |
Amirhossein Davoodvandi, Reza Asemi, Mehran Sharifi, Russel J. Reiter, Seyed Amirhassan Matini, Seyyed Mehdi Mirhashemi, Zatollah Asemi. Melatonin as a Promising Agent for Cancer Treatment: Insights into
its Effects on the Wnt/beta-catenin Signaling Pathway. Current Medicinal Chemistry 2024; 31(11): 1315 doi: 10.2174/0929867330666230409141957
|
| 21 |
Peng Xu, Kanghui Liu, Shansong Huang, Jialun Lv, Zhengyuan Yan, Han Ge, Quan Cheng, Zetian Chen, Peicheng Ji, Yawei Qian, Bowen Li, Hao Xu, Li Yang, Zekuan Xu, Diancai Zhang. N6-methyladenosine-modified MIB1 promotes stemness properties and peritoneal metastasis of gastric cancer cells by ubiquitinating DDX3X. Gastric Cancer 2024; 27(2): 275 doi: 10.1007/s10120-023-01463-5
|
| 22 |
Abdullah Al-Sawat, Jung Hoon Bea, Seung-Rim Han, Hyo Jin Lee, Mi Ran Yoon, Yoon Suk Lee, Do Sang Lee, Chul Seung Lee, In Kyu Lee. Use of ascitic CEA levels as a predictive value for distant metastasis in high-risk stage II and III colorectal cancer. International Journal of Colorectal Disease 2022; 37(2): 365 doi: 10.1007/s00384-021-04070-x
|
| 23 |
Dan Zou, Jincheng Song, Mingming Deng, Yanju Ma, Chunjiao Yang, Jiaqing Liu, Song Wang, Zhenpeng Wen, Yu Tang, Xiujuan Qu, Ye Zhang. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase‐mitogen‐activated protein kinases signaling pathway. The FASEB Journal 2021; 35(5) doi: 10.1096/fj.202002780R
|
| 24 |
Gaku Shimane, Yutaka Nakano, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Yasushi Hasegawa, Shigeyoshi Soga, Shigeo Okuda, Ryota Ishii, Yuko Kitagawa. Preoperative predictive factors for positive peritoneal cytology results in patients with pancreatic ductal adenocarcinomas: a retrospective study. International Journal of Clinical Oncology 2024; 29(7): 985 doi: 10.1007/s10147-024-02523-1
|
| 25 |
Jun Shibamoto, Tomohiro Arita, Hirotaka Konishi, Satoshi Kataoka, Hirotaka Furuke, Wataru Takaki, Kazuya Takabatake, Jun Kiuchi, Takuma Ohashi, Hiroki Shimizu, Yusuke Yamamoto, Shuhei Komatsu, Atsushi Shiozaki, Takeshi Kubota, Kazuma Okamoto, Eigo Otsuji. Removal of small extracellular vesicles inhibits the progression of peritoneal dissemination in gastric cancer. Gastric Cancer 2022; 25(4): 712 doi: 10.1007/s10120-022-01293-x
|
| 26 |
Hiroto Saito, Sachio Fushida, Shinichi Harada, Tomoharu Miyashita, Katsunobu Oyama, Takahisa Yamaguchi, Tomoya Tsukada, Jun Kinoshita, Hidehiro Tajima, Itasu Ninomiya, Tetsuo Ohta. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast. Gastric Cancer 2018; 21(1): 55 doi: 10.1007/s10120-017-0726-5
|
| 27 |
Leyla Norouzi‐Barough, Mohammad Reza Sarookhani, Mohammadreza Sharifi, Sahar Moghbelinejad, Saranaz Jangjoo, Rasoul Salehi. Molecular mechanisms of drug resistance in ovarian cancer. Journal of Cellular Physiology 2018; 233(6): 4546 doi: 10.1002/jcp.26289
|
| 28 |
Atsushi Sugimoto, Tomohisa Okuno, Gen Tsujio, Tomohiro Sera, Yurie Yamamoto, Koji Maruo, Shuhei Kushiyama, Sadaaki Nishimura, Kenji Kuroda, Shingo Togano, Yuichiro Miki, Mami Yoshii, Tatsuro Tamura, Takahiro Toyokawa, Hiroaki Tanaka, Kazuya Muguruma, Masaichi Ohira, Masakazu Yashiro, Surinder K. Batra. The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients. PLOS ONE 2021; 16(7): e0253702 doi: 10.1371/journal.pone.0253702
|
| 29 |
Toshiyuki Kosuga, Atsushi Shiozaki, Michihiro Kudou, Yuzo Yamazato, Daisuke Ichikawa, Shuhei Komatsu, Hirotaka Konishi, Kazuma Okamoto, Katsutoshi Shoda, Tomohiro Arita, Ryo Morimura, Yasutoshi Murayama, Yoshiaki Kuriu, Hisashi Ikoma, Masayoshi Nakanishi, Hitoshi Fujiwara, Yoshinori Marunaka, Eigo Otsuji. Blockade of potassium ion transports enhances hypotonicity-induced cytocidal effects in gastric cancer. Oncotarget 2017; 8(60): 101394 doi: 10.18632/oncotarget.20736
|
| 30 |
Makoto Miyazaki, Ayaka Nakabo, Yoshiko Nagano, Yuko Nagamura, Kazuyoshi Yanagihara, Rieko Ohki, Yoshikazu Nakamura, Kiyoko Fukami, Jun Kawamoto, Kenji Umayahara, Masaru Sakamoto, Keiichi Iwaya, Hideki Yamaguchi. Tissue factor-induced fibrinogenesis mediates cancer cell clustering and multiclonal peritoneal metastasis. Cancer Letters 2023; 553: 215983 doi: 10.1016/j.canlet.2022.215983
|
| 31 |
Kai‑Bo Chen, Jian Chen, Xiao‑Li Jin, Yi Huang, Qiu‑Ming Su, Li Chen. Exosome‑mediated peritoneal dissemination in gastric cancer and its clinical applications (Review). Biomedical Reports 2018; doi: 10.3892/br.2018.1088
|
| 32 |
Yanyan Chen, Quan Zhou, Haiyong Wang, Wei Zhuo, Yongfeng Ding, Jun Lu, Guanghao Wu, Nong Xu, Lisong Teng. Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers. Cancers 2020; 12(8): 2236 doi: 10.3390/cancers12082236
|
| 33 |
Tsutomu Namikawa, Keiichiro Yokota, Sachi Yamaguchi, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Masamitsu Kumon, Michiya Kobayashi, Kazuhiro Hanazaki. Evaluation of Systemic Inflammatory Response and Nutritional Biomarkers as Predictive Factors in Patients with Recurrent Gastric Cancer. Oncology 2020; 98(7): 452 doi: 10.1159/000505973
|
| 34 |
Robert Sitarz, Wojciech P Polkowski, Ryszard Maciejewski, G Johan A Offerhaus. Risk of peritoneal dissemination in stomach cancer. Current Issues in Pharmacy and Medical Sciences 2017; 30(4): 184 doi: 10.1515/cipms-2017-0034
|
| 35 |
Sabine Wislet, Geoffrey Vandervelden, Bernard Rogister. From Neural Crest Development to Cancer and Vice Versa: How p75NTR and (Pro)neurotrophins Could Act on Cell Migration and Invasion?. Frontiers in Molecular Neuroscience 2018; 11 doi: 10.3389/fnmol.2018.00244
|
| 36 |
Su-Jin Shin, Sejung Park, Min Hwan Kim, Chung Mo Nam, Hyunki Kim, Yoon Young Choi, Min Kyu Jung, Hye Jin Choi, Sun Young Rha, Hyun Cheol Chung. Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer. The Oncologist 2019; 24(11): e1108 doi: 10.1634/theoncologist.2018-0896
|
| 37 |
V. M. Khomyakov, A. B. Ryabov, L. V. Bolotina, D. D. Sobolev, A. B. Utkina, O. S. Kuznetsova. Treatment of patients with gastric cancer and peritoneal carcinomatosis: current views and perspectives. Onkologiya. Zhurnal imeni P.A.Gertsena 2017; 6(6): 4 doi: 10.17116/onkolog2017664-13
|
| 38 |
Rubén López-Cortés, Sergio Vázquez-Estévez, Javier Álvarez Fernández, Cristina Núñez. Proteomics as a Complementary Technique to Characterize Bladder Cancer. Cancers 2021; 13(21): 5537 doi: 10.3390/cancers13215537
|
| 39 |
Jong-Han Kim. Intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis. Foregut Surgery 2024; 4(1): 6 doi: 10.51666/fs.2024.4.e3
|
| 40 |
Hayemin Lee, Han Hong Lee, Chae Youn Lim, Junhyun Lee. The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei. Surgery 2021; 169(5): 1213 doi: 10.1016/j.surg.2020.11.020
|
| 41 |
Shunsuke Nakamura, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera. Accurate Risk Stratification of Patients with Node‐Positive Gastric Cancer by Lymph Node Ratio. World Journal of Surgery 2020; 44(12): 4184 doi: 10.1007/s00268-020-05739-0
|
| 42 |
Shingo Miyamoto, Yoshiko Nagano, Makoto Miyazaki, Yuko Nagamura, Kazuki Sasaki, Takeshi Kawamura, Kazuyoshi Yanagihara, Toshio Imai, Rieko Ohki, Masakazu Yashiro, Masato Tanaka, Ryuichi Sakai, Hideki Yamaguchi. Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma. Cancer Letters 2022; 526: 335 doi: 10.1016/j.canlet.2021.11.008
|
| 43 |
Yuze Ma, Yu Fu, Xiaoli Fan, Qiang Ji, XiaoJiao Duan, Yanfeng Wang, Yongmin Zhang, Zhigang Wang, Huifang Hao. FAK/IL-8 axis promotes the proliferation and migration of gastric cancer cells. Gastric Cancer 2023; 26(4): 528 doi: 10.1007/s10120-023-01384-3
|
| 44 |
Niranjan Awasthi, Margaret A. Schwarz, Changhua Zhang, Roderich E. Schwarz. Augmentation of Nab-Paclitaxel Chemotherapy Response by Mechanistically Diverse Antiangiogenic Agents in Preclinical Gastric Cancer Models. Molecular Cancer Therapeutics 2018; 17(11): 2353 doi: 10.1158/1535-7163.MCT-18-0489
|
| 45 |
Yu-Ting Sun, Shi-Xun Lu, Ming-Yu Lai, Xia Yang, Wen-Long Guan, Li-Qiong Yang, Yu-Hong Li, Feng-Hua Wang, Da-Jun Yang, Miao-Zhen Qiu. Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma. Cancer Immunology, Immunotherapy 2024; 73(8) doi: 10.1007/s00262-024-03721-6
|
| 46 |
Ryuichiro Kimura, Azusa Yoneshige, Man Hagiyama, Tomoyuki Otani, Takao Inoue, Naoki Shiraishi, Kazuyoshi Yanagihara, Tomohiko Wakayama, Akihiko Ito. Expression of cell adhesion molecule 1 in gastric neck and base glandular cells: Possible involvement in peritoneal dissemination of signet ring cells. Life Sciences 2018; 213: 206 doi: 10.1016/j.lfs.2018.10.017
|
| 47 |
Jing Gao, Song Li, Qian Xu, Xue Zhang, Miao Huang, Xin Dai, Lian Liu. Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.652378
|
| 48 |
Ilona Sadok, Katarzyna Jędruchniewicz, Karol Rawicz-Pruszyński, Magdalena Staniszewska. UHPLC-ESI-MS/MS Quantification of Relevant Substrates and Metabolites of the Kynurenine Pathway Present in Serum and Peritoneal Fluid from Gastric Cancer Patients—Method Development and Validation. International Journal of Molecular Sciences 2021; 22(13): 6972 doi: 10.3390/ijms22136972
|
| 49 |
Niels A. D. Guchelaar, Bo J. Noordman, Stijn L. W. Koolen, Bianca Mostert, Eva V. E. Madsen, Jacobus W. A. Burger, Alexandra R. M. Brandt-Kerkhof, Geert-Jan Creemers, Ignace H. J. T. de Hingh, Misha Luyer, Sander Bins, Esther van Meerten, Sjoerd M. Lagarde, Cornelis Verhoef, Bas P. L. Wijnhoven, Ron. H. J. Mathijssen. Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies. Drugs 2023; 83(2): 159 doi: 10.1007/s40265-022-01828-7
|
| 50 |
Jiaoyang Yang, Gege Shu, Tao Chen, Anqi Dong, Chao Dong, Weikang Li, Xiaotong Sun, Yajing Zhou, Dongbao Li, Jin Zhou. ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis. Cancers 2023; 16(1): 194 doi: 10.3390/cancers16010194
|
| 51 |
Yuan Jiao, Xiaobo Peng, Yujie Wang, Zhibin Hao, Ling Chen, Meihong Wu, Yingyi Zhang, Jie Li, Wenlin Li, Xianbao Zhan. Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of asparagine synthetase. Oncology Letters 2023; 26(4) doi: 10.3892/ol.2023.14005
|
| 52 |
Rosaria Meucci, Daniela Prosperi, Chiara Lauri, Giuseppe Campagna, Pallavi Nayak, Francesco Garaci, Alberto Signore. Peritoneal Carcinomatosis of Malignant Gynecological Origin: A Systematic Review of Imaging Assessment. Journal of Clinical Medicine 2024; 13(5): 1254 doi: 10.3390/jcm13051254
|
| 53 |
Annalisa Capobianco, Lucia Cottone, Antonella Monno, Angelo A Manfredi, Patrizia Rovere‐Querini. The peritoneum: healing, immunity, and diseases. The Journal of Pathology 2017; 243(2): 137 doi: 10.1002/path.4942
|
| 54 |
Wan-Ying Du, Hiroki Masuda, Koji Nagaoka, Tomohiko Yasuda, Komei Kuge, Yasuyuki Seto, Kazuhiro Kakimi, Sachiyo Nomura. Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice. Gastric Cancer 2024; 27(5): 971 doi: 10.1007/s10120-024-01514-5
|
| 55 |
Hiroko Ideo, Akiko Tsuchida, Yoshio Takada, Jun Kinoshita, Noriyuki Inaki, Toshinari Minamoto. Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells. Gastric Cancer 2023; 26(3): 352 doi: 10.1007/s10120-023-01366-5
|
| 56 |
Soon-Chan Kim, Ja-Lok Ku. Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks. 2024; : 67 doi: 10.1016/B978-0-12-824040-3.00004-2
|
| 57 |
Daniel Jose Szor, Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Bruna de Camargo Nigro, Andre Roncon Dias, Ulysses Ribeiro Jr. Peritoneal recurrence in gastric cancer after curative gastrectomy: risk factors and predictive score model. Journal of Gastrointestinal Surgery 2024; : 101850 doi: 10.1016/j.gassur.2024.10.005
|
| 58 |
Xiao-Yan Hu, Zhe Liu, Kai-Lin Zhang, Jing Feng, Xiao-Fang Liu, Ling-Yun Wang, Zi-Wei Wang. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells. Cancer Biomarkers 2017; 21(1): 195 doi: 10.3233/CBM-170651
|
| 59 |
思颖 朱. The Diagnosis and Treatment of Peritoneal Metastasis of Gastric Cancer. Advances in Clinical Medicine 2021; 11(01): 99 doi: 10.12677/ACM.2021.111014
|
| 60 |
Yukari Ono, Yoichiro Okubo, Kota Washimi, Yo Mikayama, Tsunehiro Doiuch, Chie Hasegawa, Emi Yoshioka, Kyoko Ono, Manabu Shiozawa, Tomoyuki Yokose. Primary omental smooth muscle tumor in an adult male: a diagnostic dilemma for leiomyoma: a case report. Journal of Medical Case Reports 2024; 18(1) doi: 10.1186/s13256-024-04537-9
|
| 61 |
Kazuyoshi Yanagihara, Takanori Kubo, Keichiro Mihara, Takeshi Kuwata, Atsushi Ochiai, Toshio Seyama, Hiroshi Yokozaki. Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line. Pancreas 2019; 48(3): 315 doi: 10.1097/MPA.0000000000001253
|
| 62 |
Dai Shimizu, Mitsuro Kanda, Yasuhiro Kodera. Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer. World Journal of Gastrointestinal Oncology 2018; 10(6): 124-136 doi: 10.4251/wjgo.v10.i6.124
|
| 63 |
Bernhard Gillissen, Antje Richter, Frank Essmann, Wolfgang Kemmner. Alectinib treatment improves photodynamic therapy in cancer cell lines of different origin. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08667-x
|
| 64 |
Jungmin Lee, Soo Ho Choi, Jin Ho Baek, Dong Won Baek, Jong Gwang Kim, Byung Woog Kang. Clinical Impact of Prognostic Nutrition Index for Advanced Gastric Cancer Patients with Peritoneal Metastases Treated Nivolumab Monotherapy. Chonnam Medical Journal 2022; 58(1): 24 doi: 10.4068/cmj.2022.58.1.24
|
| 65 |
Ping’an Ding, Haotian Wu, Jiaxiang Wu, Tongkun Li, Renjun Gu, Lilong Zhang, Peigang Yang, Honghai Guo, Yuan Tian, Jinchen He, Jiaxuan Yang, Ning Meng, Xiaolong Li, Lingjiao Meng, Qun Zhao. Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03098-5
|
| 66 |
K. S. Titov, A. A. Kuzmenko, Z. A. Bagatelia, D. N. Grekov, V. N. Yakomaskin, T. V. Petrosyan. Current opportunities for combined treatment of gastric cancer patients with peritoneal carcinomatosis. Malignant tumours 2023; 13(4): 69 doi: 10.18027/2224-5057-2023-13-4-69-77
|
| 67 |
Bingqiang Li, Guofeng Qu. Inhibition of the hypoxia-induced factor-1α and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells. Journal of Cancer Research and Therapeutics 2019; 15(7): 1642 doi: 10.4103/jcrt.JCRT_77_17
|
| 68 |
Qingjiang Hu, Takaaki Masuda, Shotaro Kuramitsu, Taro Tobo, Kuniaki Sato, Shinya Kidogami, Sho Nambara, Masami Ueda, Yusuke Tsuruda, Yosuke Kuroda, Shuhei Ito, Eiji Oki, Masaki Mori, Koshi Mimori, Joseph Najbauer. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT. PLOS ONE 2020; 15(10): e0241140 doi: 10.1371/journal.pone.0241140
|
| 69 |
Takahiro Shinozuka, Mitsuro Kanda, Yasuhiro Kodera. Site-specific protein biomarkers in gastric cancer: a comprehensive review of novel biomarkers and clinical applications. Expert Review of Molecular Diagnostics 2023; 23(8): 701 doi: 10.1080/14737159.2023.2232298
|
| 70 |
Yuanfang Li, Yongqiang Zheng, Jiaqian Huang, Run-Cong Nie, Qi-Nian Wu, Zhijun Zuo, Shuqiang Yuan, Kai Yu, Cheng-Cai Liang, Yi-Qian Pan, Bai-Wei Zhao, Yuhong Xu, Qihua Zhang, Yashang Zheng, Junquan Chen, Zhao-Lei Zeng, Wei Wei, Ze-Xian Liu, Rui-Hua Xu, Hui-Yan Luo. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut 2024; : gutjnl-2024-333617 doi: 10.1136/gutjnl-2024-333617
|
| 71 |
Keisuke Goto, Masaki Morimoto, Mitsuhiko Osaki, Akimitsu Tanio, Runa Izutsu, Yoshiyuki Fujiwara, Futoshi Okada. The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09339-0
|
| 72 |
Hyunjin Kim, Sujin Park, So Young Kang, Soomin Ahn, Kyoung-Mee Kim. Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden. Diagnostics 2022; 12(10): 2355 doi: 10.3390/diagnostics12102355
|
| 73 |
Elham Ghadami, Novin Nikbakhsh, Sadegh Fattahi, Mohadeseh Kosari‐Monfared, Mohammad Ranaee, Hassan Taheri, Fatemeh Amjadi‐Moheb, Gholamali Godazandeh, Shahryar Shafaei, Anahita Nosrati, Maryam Pilehchian Langroudi, Ali Akbar Samadani, Galia Amirbozorgi, Vahideh Mirnia, Haleh Akhavan‐Niaki. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections. Journal of Cellular Physiology 2019; 234(4): 4115 doi: 10.1002/jcp.27220
|
| 74 |
Meghan Grojean, Margaret A. Schwarz, Johann R. Schwarz, Sazzad Hassan, Urz von Holzen, Changhua Zhang, Roderich E. Schwarz, Niranjan Awasthi. Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models. Journal of Cellular and Molecular Medicine 2021; 25(11): 4950 doi: 10.1111/jcmm.16362
|
| 75 |
Daisuke Sasaki, Hinako Suzuki, Kosuke Kusamori, Shoko Itakura, Hiroaki Todo, Makiya Nishikawa. Development of rice bran-derived nanoparticles with excellent anti-cancer activity and their application for peritoneal dissemination. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02381-z
|
| 76 |
Riping Wu, Qiaolian Li, Fan Wu, Chunmei Shi, Qiang Chen. <p>Comprehensive Analysis of <em>CDC27</em> Related to Peritoneal Metastasis by Whole Exome Sequencing in Gastric Cancer</p>. OncoTargets and Therapy 2020; : 3335 doi: 10.2147/OTT.S244351
|
| 77 |
Junhua Zhao, Zhaojun Han, Chang Xu, Lu Li, Haimeng Pei, Yongxi Song, Zhenning Wang, Bo Tang. Separation and Single-Cell Analysis for Free Gastric Cancer Cells in Ascites and Peritoneal Lavages Based on Microfluidic Chips. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4117355
|
| 78 |
Dandan Bao, Zhangwei Yang, Senrui Chen, Keqin Li, Yiren Hu. Construction of a Nomogram Model for Predicting Peritoneal Dissemination in Gastric Cancer Based on Clinicopathologic Features and Preoperative Serum Tumor Markers. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.844786
|
| 79 |
Deanna Ng, Aiman Ali, Kiera Lee, Denise Eymael, Kento Abe, Shelly Luu, Karineh Kazazian, Yi Qing Lu, Savtaj Brar, James Conner, Marco Magalhaes, Carol J. Swallow. Investigating the mechanisms of peritoneal metastasis in gastric adenocarcinoma using a novel ex vivo peritoneal explant model. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13948-x
|
| 80 |
Toshiya Abe, Kenoki Ohuchida, Kazuhiro Koikawa, Sho Endo, Takashi Okumura, Masafumi Sada, Kohei Horioka, Biao Zheng, Taiki Moriyama, Kohei Nakata, Yoshihiro Miyasaka, Tatsuya Manabe, Takao Ohtsuka, Eishi Nagai, Kazuhiro Mizumoto, Makoto Hashizume, Masafumi Nakamura. Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination. International Journal of Oncology 2017; 50(2): 457 doi: 10.3892/ijo.2016.3829
|
| 81 |
Hyejin Jin, In-Hye Ham, Hye Jeong Oh, Cheong A Bae, Dakeun Lee, Young-Bae Kim, Sang-Yong Son, Yong-Joon Chwae, Sang-Uk Han, Rolf A. Brekken, Hoon Hur. Inhibition of Discoidin Domain Receptor 1 Prevents Stroma-Induced Peritoneal Metastasis in Gastric Carcinoma. Molecular Cancer Research 2018; 16(10): 1590 doi: 10.1158/1541-7786.MCR-17-0710
|
| 82 |
Yuki Kiyozumi, Masaaki Iwatsuki, Junji Kurashige, Yoko Ogata, Kohei Yamashita, Yuki Koga, Tasuku Toihata, Yukiharu Hiyoshi, Takatsugu Ishimoto, Yoshifumi Baba, Yuji Miyamoto, Naoya Yoshida, Kazuyoshi Yanagihara, Koshi Mimori, Hideo Baba. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer. International Journal of Cancer 2018; 143(5): 1202 doi: 10.1002/ijc.31410
|
| 83 |
Wei Zong, Wei Feng, Yun Jiang, Shaoqing Ju, Ming Cui, Rongrong Jing. Evaluating the diagnostic and prognostic value of serum long non-coding RNA CTC-497E21.4 in gastric cancer. Clinical Chemistry and Laboratory Medicine (CCLM) 2019; 57(7): 1063 doi: 10.1515/cclm-2018-0929
|
| 84 |
Sara K. Daniel, Y. David Seo, Venu G. Pillarisetty. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Seminars in Cancer Biology 2020; 65: 176 doi: 10.1016/j.semcancer.2019.12.007
|
| 85 |
Eva Ruiz Hispán, Manuel Pedregal, Ion Cristobal, Jesús García-Foncillas, Cristina Caramés. Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials. Journal of Clinical Medicine 2021; 10(20): 4649 doi: 10.3390/jcm10204649
|
| 86 |
Pablo Astudillo. Wnt5a Signaling in Gastric Cancer. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00110
|
| 87 |
Niranjan Awasthi, Margaret A. Schwarz, Changhua Zhang, Stephan G. Klinz, Florence Meyer-Losic, Benjamin Beaufils, Arunthathi Thiagalingam, Roderich E. Schwarz. Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy. Molecular Cancer Therapeutics 2022; 21(7): 1149 doi: 10.1158/1535-7163.MCT-21-0860
|
| 88 |
Guodong Chen, Na Tang, Chao Wang, Linqiao Xiao, Minjun Yu, Lanhua Zhao, Hengling Cai, Liang Han, Chengyuan Xie, Yan Zhang. TNF-α-inducing protein of Helicobacter pylori induces epithelial-mesenchymal transition (EMT) in gastric cancer cells through activation of IL-6/STAT3 signaling pathway. Biochemical and Biophysical Research Communications 2017; 484(2): 311 doi: 10.1016/j.bbrc.2017.01.110
|
| 89 |
Kohei Ueno, Kenta Horita, Nobuaki Hoshino, Koya Hida, Norio Watanabe. Extensive intraoperative peritoneal lavage for resectable advanced gastric cancer. Cochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD014950
|
| 90 |
Hikaru Hayashi, Akira Shimizu, Hiroaki Motoyama, Koji Kubota, Tsuyoshi Notake, Shinsuke Sugenoya, Kiyotaka Hosoda, Koya Yasukawa, Ryoichiro Kobayashi, Yuji Soejima. Usefulness and limitation of indocyanine green fluorescence for detection of peritoneal recurrence after hepatectomy for hepatocellular carcinoma: a case report. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01111-8
|
| 91 |
Niranjan Awasthi, Margaret A. Schwarz, Quinn Kaurich, Changhua Zhang, Frank Hilberg, Roderich E. Schwarz. Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1145999
|
| 92 |
Koichi Sawaki, Mitsuro Kanda, Takashi Miwa, Shinichi Umeda, Haruyoshi Tanaka, Chie Tanaka, Daisuke Kobayashi, Masaya Suenaga, Norifumi Hattori, Masamichi Hayashi, Suguru Yamada, Goro Nakayama, Michitaka Fujiwara, Yasuhiro Kodera. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer. Annals of Surgical Oncology 2018; 25(7): 2083 doi: 10.1245/s10434-018-6480-z
|
| 93 |
Junhua Zhao, Zhaojun Han, Chang Xu, Lu Li, Haimeng Pei, Yongxi Song, Zhenning Wang, Bo Tang. Separation and single-cell analysis for free gastric cancer cells in ascites and peritoneal lavages based on microfluidic chips. eBioMedicine 2023; 90: 104522 doi: 10.1016/j.ebiom.2023.104522
|
| 94 |
Ting Yu, Li Gong, Wei Li, Qianfei Zuo, Dongping Cai, Hui Mao, Lina Wang, Jie Lin, Bin Xiao. MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα. Cancer Biomarkers 2020; 27(4): 471 doi: 10.3233/CBM-190314
|
| 95 |
Donghoon Kang, In-Ho Kim. Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer. Biomedicines 2022; 10(6): 1376 doi: 10.3390/biomedicines10061376
|
| 96 |
Mefotse Saha Cyrelle Ornella, Narayanasamy Badrinath, Kyeong-Ae Kim, Jung Hee Kim, Euna Cho, Tae-Ho Hwang, Jae-Joon Kim. Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes. Cancers 2023; 15(8): 2383 doi: 10.3390/cancers15082383
|
| 97 |
Mitsuro Kanda, Dai Shimizu, Haruyoshi Tanaka, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Naoki Iwata, Yukiko Niwa, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Kenta Murotani, Michitaka Fujiwara, Yasuhiro Kodera. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. Annals of Surgery 2018; 267(3): 495 doi: 10.1097/SLA.0000000000002096
|
| 98 |
Roberto Camacho Barranco, Raimundo F. Dos Santos, M. Shahriar Hossain, Monika Akbar. Tracking the Evolution of Words with Time-reflective Text Representations. 2018 IEEE International Conference on Big Data (Big Data) 2018; : 2088 doi: 10.1109/BigData.2018.8621902
|
| 99 |
Koki Nakanishi, Mitsuro Kanda, Shinichi Umeda, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Suguru Yamada, Yasuhiro Kodera. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer. Gastric Cancer 2019; 22(6): 1143 doi: 10.1007/s10120-019-00967-3
|
| 100 |
Ali Alemdar, Mehmet Güray Duman, Selma Şengiz Erhan, Ali Güner, İsmayil Yılmaz. Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. The Journal of Tepecik Education and Research Hospital 2023; 33(1): 85 doi: 10.4274/terh.galenos.2022.82997
|
| 101 |
Xuanrong Fu, Qimeng Wang, Hang Du, Huifang Hao. CXCL8 and the peritoneal metastasis of ovarian and gastric cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1159061
|
| 102 |
Meloria A. Hoskins, Adam Finkelstein, Aisha Rashid, Olivia Ziegler, Marc M. Mankarious, Jorge V. Benavides, Colette R. Pameijer. Data-Driven Surveillance Protocol for Patients at Risk for Peritoneal Recurrence of Primary Colon Cancer: Surveillance for Peritoneal Carcinomatosis. Journal of Clinical Medicine 2024; 13(8): 2358 doi: 10.3390/jcm13082358
|
| 103 |
Yanting Hu, Changsong Qi, Xiang Liu, Cheng Zhang, Jing Gao, Yi Wu, Jing Yang, Qian Zhao, Jian Li, Xiaojuan Wang, Lin Shen. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer. Cancer Letters 2019; 457: 142 doi: 10.1016/j.canlet.2019.04.034
|
| 104 |
Augustinas Bausys, Zilvinas Gricius, Laura Aniukstyte, Martynas Luksta, Klaudija Bickaite, Rimantas Bausys, Kestutis Strupas. Current treatment strategies for patients with only peritoneal cytology positive stage IV gastric cancer. World Journal of Clinical Cases 2021; 9(32): 9711-9721 doi: 10.12998/wjcc.v9.i32.9711
|
| 105 |
Leela Rani Avula, Brendan Hagerty, Christine Alewine. Molecular mediators of peritoneal metastasis in pancreatic cancer. Cancer and Metastasis Reviews 2020; 39(4): 1223 doi: 10.1007/s10555-020-09924-4
|
| 106 |
Ziting Qu, Qianling Wang, Hui Wang, Yang Jiao, Min Li, Wei Wei, Yu Lei, Zhiyan Zhao, Tengteng Zhang, Yiyin Zhang, Kangsheng Gu. The Effect of Inflammatory Markers on the Survival of Advanced Gastric Cancer Patients Who Underwent Anti-Programmed Death 1 Therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.783197
|
| 107 |
Timothy Masiello, Atul Dhall, L. P. Madhubhani Hemachandra, Natalya Tokranova, J. Andres Melendez, James Castracane. A Dynamic Culture Method to Produce Ovarian Cancer Spheroids under Physiologically-Relevant Shear Stress. Cells 2018; 7(12): 277 doi: 10.3390/cells7120277
|
| 108 |
Shinichi Umeda, Mitsuro Kanda, Yasuhiro Kodera. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2019; 19(8): 725 doi: 10.1080/14737159.2019.1638254
|
| 109 |
Pengpeng Liu, Ping’an Ding, Haotian Wu, Jiaxiang Wu, Peigang Yang, Yuan Tian, Honghai Guo, Qun Zhao. Prediction of occult peritoneal metastases or positive cytology using CT in gastric cancer. European Radiology 2023; 33(12): 9275 doi: 10.1007/s00330-023-09854-z
|
| 110 |
Hidenori Ando, Masakazu Fukushima, Kiyoshi Eshima, Taichi Hasui, Taro Shimizu, Yu Ishima, Cheng‐Long Huang, Hiromi Wada, Tatsuhiro Ishida. A novel intraperitoneal therapy for gastric cancer with DFP‐10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model. Cancer Medicine 2019; 8(17): 7313 doi: 10.1002/cam4.2598
|
| 111 |
Ricardo Coelho, Sara Ricardo, Ana Luísa Amaral, Yen-Lin Huang, Mariana Nunes, José Pedro Neves, Nuno Mendes, Mónica Nuñez López, Carla Bartosch, Verónica Ferreira, Raquel Portugal, José Manuel Lopes, Raquel Almeida, Viola Heinzelmann-Schwarz, Francis Jacob, Leonor David. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation. Oncogenesis 2020; 9(6) doi: 10.1038/s41389-020-00246-2
|
| 112 |
Teruaki Oku, Kentaro Shimada, Hiroki Kenmotsu, Yusuke Ando, Chisato Kurisaka, Rikio Sano, Makoto Tsuiji, Shinya Hasegawa, Tetsuya Fukui, Tsutomu Tsuji. Stimulation of Peritoneal Mesothelial Cells to Secrete Matrix Metalloproteinase-9 (MMP-9) by TNF-α: A Role in the Invasion of Gastric Carcinoma Cells. International Journal of Molecular Sciences 2018; 19(12): 3961 doi: 10.3390/ijms19123961
|
| 113 |
Toru Yanoma, Kyoichi Ogata, Takehiko Yokobori, Munenori Ide, Erito Mochiki, Yoshitaka Toyomasu, Mitsuhiro Yanai, Norimichi Kogure, Akiharu Kimura, Masaki Suzuki, Nobuhiro Nakazawa, Tuya Bai, Tetsunari Oyama, Takayuki Asao, Ken Shirabe, Hiroyuki Kuwano. Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70. Oncology Reports 2017; 38(3): 1500 doi: 10.3892/or.2017.5844
|
| 114 |
Vítor Devezas, Manuela Baptista, Irene Gullo, João Rocha, Fabiana Sousa, Wen Xiaogang, John Preto, Susy Costa, Sérgio Castedo, Luzia Garrido, Carla Oliveira, Elisabete Barbosa, Fátima Carneiro, José Barbosa. Risk-reducing total gastrectomy in asymptomatic CDH1 carriers. European Surgery 2020; 52(4): 171 doi: 10.1007/s10353-020-00630-7
|
| 115 |
Eiji Kasumi, Norifumi Sato. A ketogenic diet improves the prognosis in a mouse model of peritoneal dissemination without tumor regression. Journal of Clinical Biochemistry and Nutrition 2019; 64(3): 201 doi: 10.3164/jcbn.18-103
|